Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

During the coronavirus disease-2019 (COVID-19) pandemic, which was caused by the novel coronavirus, there is an ongoing controversy about the use of corticosteroids. This study aims to investigate the association between Dexamethasone treatment and clinical outcomes in patients with severe COVID-19...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mahnaz Montazeri, Marzieh Pazoki, Azar Hadadi, Melika Shafeghat, Abdolazim Veisizadeh, Mohammad Reza Khajavi, Farhad Najmeddin, Samira Kafan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Tehran University of Medical Sciences 2022-08-01
Serie:	Acta Medica Iranica
Soggetti:	Coronavirus disease 2019 (COVID-19) Dexamethasone Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Corticosteroid Mortality
Accesso online:	https://acta.tums.ac.ir/index.php/acta/article/view/9967
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!